US Patent Issued to SkylineDx, Mayo Foundation for Medical Education and Research on Nov. 18 for "Gene signatures for predicting metastasis of melanoma and patient prognosis" (Dutch, American Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,599, issued on Nov. 18, was assigned to SkylineDx B.V. (Rotterdam, Netherlands) and Mayo Foundation for Medical Education and Research (Rochester, Minn.).

"Gene signatures for predicting metastasis of melanoma and patient prognosis" was invented by Alexander Meves (Rochester, Minn.) and Domenico Bellomo (The Hague, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides gene signatures of classifying an individual afflicted with cutaneous melanoma. The "SLN gene signatures" provided herein classify an individual based on prognosis and/or classify an individual as having a metastasis-positive or -negative sentinel lymph nod...